GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shandong Weigao Group Medical Polymer Co Ltd (OTCPK:SHWGY) » Definitions » Debt-to-Revenue

Shandong Weigao Group Medical Polymer Co (Shandong Weigao Group Medical Polymer Co) Debt-to-Revenue : 0.32 (As of Jun. 2023)


View and export this data going back to 2011. Start your Free Trial

What is Shandong Weigao Group Medical Polymer Co Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Shandong Weigao Group Medical Polymer Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was $127 Mil. Shandong Weigao Group Medical Polymer Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was $479 Mil. Shandong Weigao Group Medical Polymer Co's annualized Revenue for the quarter that ended in Jun. 2023 was $1,926 Mil. Shandong Weigao Group Medical Polymer Co's annualized Debt-to-Revenue for the quarter that ended in Jun. 2023 was 0.31.


Shandong Weigao Group Medical Polymer Co Debt-to-Revenue Historical Data

The historical data trend for Shandong Weigao Group Medical Polymer Co's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Weigao Group Medical Polymer Co Debt-to-Revenue Chart

Shandong Weigao Group Medical Polymer Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.53 0.37 0.31 0.33 0.32

Shandong Weigao Group Medical Polymer Co Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.30 0.32 0.34 0.32 0.33

Competitive Comparison of Shandong Weigao Group Medical Polymer Co's Debt-to-Revenue

For the Medical Instruments & Supplies subindustry, Shandong Weigao Group Medical Polymer Co's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shandong Weigao Group Medical Polymer Co's Debt-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shandong Weigao Group Medical Polymer Co's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Shandong Weigao Group Medical Polymer Co's Debt-to-Revenue falls into.



Shandong Weigao Group Medical Polymer Co Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Shandong Weigao Group Medical Polymer Co's Debt-to-Revenue for the fiscal year that ended in Dec. 2022 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(142.021 + 502.211) / 1953.47
=0.33

Shandong Weigao Group Medical Polymer Co's annualized Debt-to-Revenue for the quarter that ended in Jun. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(127.178 + 479.296) / 1926.356
=0.31

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is two times the quarterly (Jun. 2023) Revenue data.


Shandong Weigao Group Medical Polymer Co Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Shandong Weigao Group Medical Polymer Co's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Shandong Weigao Group Medical Polymer Co (Shandong Weigao Group Medical Polymer Co) Business Description

Traded in Other Exchanges
Address
No.1, Weigao Road, Torch Hi-tech Science Park, Shandong Province, Weihai, CHN
Shandong Weigao Group Medical Polymer Co Ltd functions in the healthcare sector in China. Its business mainly involves the research and development, production, and sale of single-use medical device products. The company's segments include Medical device products, Orthopaedic products, Interventional products, Pharma packaging products, Blood management products, and others. The company's products comprise consumables including infusion sets, syringes, medical needles, blood bags, prefilled syringes, wound management, blood sampling products; orthopedic materials, and blood purification consumables and equipment. The company operates in the People's Republic of China, the United States, Europe, the Middle East, and Africa, Asia, and others.

Shandong Weigao Group Medical Polymer Co (Shandong Weigao Group Medical Polymer Co) Headlines